These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 10023702

  • 1. Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia.
    Ross JF, Wang H, Behm FG, Mathew P, Wu M, Booth R, Ratnam M.
    Cancer; 1999 Jan 15; 85(2):348-57. PubMed ID: 10023702
    [Abstract] [Full Text] [Related]

  • 2. Differentiation-independent retinoid induction of folate receptor type beta, a potential tumor target in myeloid leukemia.
    Wang H, Zheng X, Behm FG, Ratnam M.
    Blood; 2000 Nov 15; 96(10):3529-36. PubMed ID: 11071651
    [Abstract] [Full Text] [Related]

  • 3. Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity.
    Shen F, Ross JF, Wang X, Ratnam M.
    Biochemistry; 1994 Feb 08; 33(5):1209-15. PubMed ID: 8110752
    [Abstract] [Full Text] [Related]

  • 4. Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis.
    Terstappen LW, Safford M, Könemann S, Loken MR, Zurlutter K, Büchner T, Hiddemann W, Wörmann B.
    Leukemia; 1992 Jan 08; 6(1):70-80. PubMed ID: 1540262
    [Abstract] [Full Text] [Related]

  • 5. Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid.
    Pan XQ, Zheng X, Shi G, Wang H, Ratnam M, Lee RJ.
    Blood; 2002 Jul 15; 100(2):594-602. PubMed ID: 12091353
    [Abstract] [Full Text] [Related]

  • 6. Stromal-mediated down-regulation of CD13 in bone marrow cells originating from acute myeloid leukemia patients.
    Dybkaer K, Olesen G, Pedersen FS, Kristensen JS.
    Eur J Haematol; 2001 Mar 15; 66(3):168-77. PubMed ID: 11350485
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F, Chen Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug 15; 15(4):687-91. PubMed ID: 17708783
    [Abstract] [Full Text] [Related]

  • 11. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y.
    Ai Zheng; 2007 Apr 15; 26(4):418-22. PubMed ID: 17430665
    [Abstract] [Full Text] [Related]

  • 12. Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression.
    Adriaansen HJ, te Boekhorst PA, Hagemeijer AM, van der Schoot CE, Delwel HR, van Dongen JJ.
    Blood; 1993 Jun 01; 81(11):3043-51. PubMed ID: 8098967
    [Abstract] [Full Text] [Related]

  • 13. Acute myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
    Mesárosová A, Hrivnáková A, Babusíková O.
    Neoplasma; 1993 Jun 01; 40(6):341-5. PubMed ID: 8289964
    [Abstract] [Full Text] [Related]

  • 14. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M, Kusenda J, Babusikova O.
    Neoplasma; 2005 Jun 01; 52(3):211-8. PubMed ID: 15875082
    [Abstract] [Full Text] [Related]

  • 15. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
    Janossy G, Coustan-Smith E, Campana D.
    Leukemia; 1989 Mar 01; 3(3):170-81. PubMed ID: 2465463
    [Abstract] [Full Text] [Related]

  • 16. The value of CD64 expression in distinguishing acute myeloid leukemia with monocytic differentiation from other subtypes of acute myeloid leukemia: a flow cytometric analysis of 64 cases.
    Dunphy CH, Tang W.
    Arch Pathol Lab Med; 2007 May 01; 131(5):748-54. PubMed ID: 17488160
    [Abstract] [Full Text] [Related]

  • 17. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR, Wang YZ, Chen SS, Chang Y, Fu JY, Li LD, Wang H, Yu H, Jiang B, Huang XJ.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov 01; 28(11):731-6. PubMed ID: 18457262
    [Abstract] [Full Text] [Related]

  • 18. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS, Medeiros LJ, Chang KL, Brynes RK, Slovak ML, Arber DA.
    Am J Clin Pathol; 1998 Feb 01; 109(2):211-20. PubMed ID: 9583894
    [Abstract] [Full Text] [Related]

  • 19. Immunophenotypic pattern of myeloid populations by flow cytometry analysis.
    Gorczyca W, Sun ZY, Cronin W, Li X, Mau S, Tugulea S.
    Methods Cell Biol; 2011 Feb 01; 103():221-66. PubMed ID: 21722806
    [Abstract] [Full Text] [Related]

  • 20. Differentiation and cell-type-restricted expression of HOXC4, HOXC5 and HOXC6 in myeloid leukemias and normal myeloid cells.
    Bijl JJ, van Oostveen JW, Walboomers JM, Brink AT, Vos W, Ossenkoppele GJ, Meijer CJ.
    Leukemia; 1998 Nov 01; 12(11):1724-32. PubMed ID: 9823947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.